Financial Performance - The estimated net profit attributable to shareholders for 2023 is projected to be between 15 million to 18 million CNY, representing a decrease of 63.43% to 56.11% compared to the previous year's profit of 41.01 million CNY[3] - The gross profit margin for 2023 is expected to decrease by 14.10 percentage points year-on-year[5] Revenue Changes - Revenue from food packaging equipment decreased by 61.41% year-on-year, while revenue from pharmaceutical packaging equipment increased by 21.29%[4] Expense Trends - Sales expenses increased year-on-year due to the recovery of the international market and the opening of exhibition activities[5] - Management expenses also increased year-on-year due to the operations of newly established subsidiaries[5] Financial Reporting - The financial data presented is preliminary and unaudited, with the final figures to be disclosed in the annual report[6]
春光药装(838810) - 2023 Q4 - 年度业绩预告